Perspective

• Consider Vitamin D in Alzheimer's Prevention and Management   Dr Richard Isaacson on vitamin D supplementation's possible role in combating Alzheimer's dementia.
  Medscape Neurology, November 18, 2019
• Time to Rethink Renal Dosing of Lamivudine?   Dose reductions of lamivudine may not be necessary for all patients with mild to moderate renal impairment, says Dr Paul Sax.
  Medscape HIV/AIDS, November 18, 2019
• AHA 2019The ISCHEMIA Trial -- Cardiology Changes Today The AHA late-breaking trial comparing an invasive vs medical strategy for patients with stable ischemic disease validates Nobel prize-winning medical conservative Bernard Lown, writes John Mandrola, MD.
  Medscape Medical News, November 17, 2019
• Nov 15 2019 This Week in Cardiology   Interruption of oral anticoagulation, marijuana and stroke, ORBITA substudy, ISCHEMIA medical therapy targets, and more on AHA are the topics discussed by Dr. John Mandrola in this week’s podcast.
  theheart.org on Medscape, November 15, 2019
• AIBD 2019 Featured News
  Medscape, November 15, 2019
• The Week That Wasn't: New Virus, Child Dementia Treatment, Chemo Bubbles Three medical stories that we didn't cover, explained.
  Medscape, November 15, 2019
• Why Is Mistreatment in Medicine Still Rampant?   Dr Alok Patel discusses mistreatment in medicine and asks how to make the necessary cultural changes we need.
  Medscape Hospital Medicine, November 15, 2019
• Iron Supplementation: How Much Is Enough? Iron supplements can be pretty miserable to take. What is the minimum amount that is both effective and tolerable?
  Medscape Internal Medicine, November 15, 2019
• The Role of Non-statin Therapy for Secondary Prevention of ASCVD A 64-year-old woman with a significant medical history sees her cardiologist for a routine follow-up after a second MI. How do you minimize her risk for future ASCVD events?
  American College of Cardiology & Medscape , November 15, 2019
• Has Sitting Gotten a Bum Rap? How much sitting is hazardous to your health? This debate may shatter many preconceived notions about sedentary behavior.
  Medscape Diabetes & Endocrinology, November 15, 2019
• Family History Is Never 'Noncontributory'   Dr Mark Lewis discusses how a few seemingly insignificant health details 'cast my entire family in a different light.'
  Medscape Oncology, November 15, 2019
• A 25-Year-Old Man With Itchy Lesions: USMLE Question A 25-year-old man presents with itchy lesions on his legs and arms. He states that the lesions developed over a week and that he has never had anything like this before. What treatment is best?
  Osmosis, November 15, 2019
• Influenza RC Clinical Guidelines
  Medscape, November 13, 2019
• The Charlie Brown of Supplements Strikes Out Again   Vitamin D and fish oil fall flat again in type 2 diabetes and chronic kidney disease. But this is not a bad thing, says Dr F. Perry Wilson.
  Medscape, November 13, 2019
• Double Trouble: 4 Things to Do in Patients With Diplopia A guide for discerning whether the cause of new-onset diplopia is benign or potentially life-threatening.
  Medscape Ophthalmology, November 13, 2019
• The Case Against Clinical Guidelines Deviations from guidelines should be viewed not as an irregularity, but as individualized and human-oriented medicine, argues Talal Hilal, MD.
  Medscape Oncology, November 12, 2019
• ACAAI 2019 Read clinically focused news coverage of key developments from ACAAI 2019
  Medscape Allergy & Immunology, November 12, 2019
• Physician-Turned-Counselor Helps Docs Overcome Career Anxiety Dr Andrew Wilner speaks with career counselor Dr Heather Fork on how physicians can deal with stress at all stages of their careers.
  Medscape Neurology, November 12, 2019
• Mandrola Previews 2019 AHA and the ISCHEMIA Trial All eyes will be on ISCHEMIA in Philadelphia, but a study on asymptomatic aortic stenosis as well as trials in heart failure and cardiogenic shock also piqued Dr John Mandrola's interest.
  theheart.org on Medscape, November 12, 2019
• Promising Biomarkers for Diabetic Nephropathy A big-data analysis identifies various glycolytic pathway enzymes, particularly PKM2, that could serve as potential therapeutic targets for diabetic kidney disease.
  Medscape Nephrology, November 12, 2019